LY2979165 is primarily utilized in the field of medical research, particularly in the study of neurological disorders. It functions as a potent and selective inhibitor of certain enzymes that are implicated in the progression of diseases such as Alzheimer's and Parkinson's. By targeting these specific enzymes, LY2979165 helps researchers understand the biochemical pathways involved in neurodegeneration, providing insights that could lead to the development of novel therapeutic strategies. Additionally, its application in preclinical studies aids in evaluating the efficacy and safety of potential treatments before they are tested in human clinical trials. This makes LY2979165 a valuable tool in the ongoing quest to combat debilitating neurological conditions.